Alibaba Health Information Technology Limited
Alibaba Health Information Technology Limited (ALBBY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
albby · pe ratio · data through Mar 31, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Alibaba Health Information Technology Limited (ALBBY) measures how much investors pay for each dollar of the company's trailing earnings. ALBBY's current PE ratio of 18.83x is calculated by dividing its stock price of $9.01 by its TTM earnings per share of $0.16. −90.3% discount vs 5Y avg 194.3x
Source: FMP · /ratios-ttm · /analyst-estimates · 2026-03-31
PE Ratio History
2007 – 2026 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 5 fiscal years · Front-end computedMinQ1 · 25%48.6x
MedianQ3 · 75%722.1x
Max
At 18.83x, ALBBY's current P/E is lower than in 0% of its annual fiscal year readings over the past 5 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Pharmaceuticals · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Alibaba Health Information Technology LimitedYou ALBBY | $7.3B | 18.83x | -42.6% | $0.16 |
 Bangkok Dusit Medical Services Public Company Limited BDUUY | $10.0B | 20.12x | -38.6% | $38.24 |
 bioMérieux S.A. BMXMF | $9.9B | 32.65x | -0.4% | $3.37 |
 Cochlear Limited CHEOF | $4.6B | 47.57x | +45.0% | $5.93 |
 Cochlear Limited CHEOY | $4.6B | 50.44x | +53.8% | $2.97 |
 CSPC Pharmaceutical Group Limited CHJTF | $12.0B | 22.34x | -31.9% | $0.33 |
 Eurofins Scientific SE ERFSF | $12.7B | 23.65x | -27.9% | $2.64 |
Industry Average 6 peers with valid PE | — | 32.79x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2026-03-31Latest FY2026 | 29.76x | $2.33 | -38.7% | |
2025-03-31 FY2025 | 48.56x | $1.78 | +7.0% | |
2024-03-31 FY2024 | 45.38x | $1.25 | -63.9% | |
2023-03-31 FY2023 | 125.59x | $0.79 | — | |
2022-03-31 FY2022 | — | $-0.39 | — | |
2021-03-31 FY2021 | 722.06x | $0.53 | — | |
2020-03-31 FY2020 | — | $-0.01 | — | |
2019-03-31 FY2019 | — | $-0.15 | — | |
2018-03-31 FY2018 | — | $-0.23 | — | |
2017-03-31 FY2017 | — | $-0.51 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Alibaba Health Information Technology Limited (ALBBY) measures how much investors pay for each dollar of the company's trailing earnings. ALBBY's current PE ratio of 18.83x is calculated by dividing its stock price of $9.01 by its TTM earnings per share of $0.16.
Frequently asked questions
ALBBY pe ratio · 6 questionsALBBY's current PE ratio is 18.83x as of 2026-06-08, based on a stock price of $9.01 and TTM EPS of $0.16. Data sourced from Financial Modeling Prep via ALBBY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Alibaba Health Information Technology Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08